Pillstats
Rx only · Injection, Solution · Intravenous

Dextrose

Brands: Infant Dextrose · Dextrose Monohydrate

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4850
US makers4 labelers
Packages11
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.7K3.4K5.1K6.8K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.2K
Rx · 2026 Q1
2.2M
Units dispensed
-29%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
ICU Medical Inc.unknown5SUPPLYING
B. Braun Medical Inc.unknown3SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown2SUPPLYING
Henry Schein Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 11, 2024
    SHORTAGEDrug shortage: Dextrose Monohydrate 70% Injection (Otsuka ICU Medical LLC)

    Dextrose Monohydrate 70% Injection — reported in shortage by Otsuka ICU Medical LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Other, Pediatric.